Remove Patients Remove Presentation Remove Treatment
article thumbnail

Study: Cannabis Safe and Effective in Fibromyalgia Patients

NORML

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279
article thumbnail

Wisconsin NORML: Presenting a United Front of Advocacy, Education and Reform

NORML

After a long day of meetings and presentations, what republican policymakers seemed to be continuously asking for was evidence, proof, more information and testimony about the efficacy of cannabis for medicinal purposes in particular. .” Before beginning treatment with CBD oil, she was on six prescription medications.

Advocacy 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Epilepsy and MMJ: Exploring the Promising Treatment Benefits

MMJ Recs

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).

Epilepsy 105
article thumbnail

The Veterans Equal Access Act Reintroduced

NORML

Presently, V.A. Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. This simple bill would align veterans VA treatment with their very popular state laws, usually approved by the voters.

Access 232
article thumbnail

Migraine Patients: 82% Say Marijuana Works

CannaMD

Read on to learn how medical marijuana helps migraines and headaches, and why neurologists are increasingly optimistic about this non-traditional treatment! The present study relied on Migraine Buddy , a leading mobile application that tracks migraine symptoms. 30 percent of migraine patients in the U.S. The results?

Patients 105
article thumbnail

CBD Enhances Glucose Metabolism via Nuclear Receptors

Project CBD

5 The paper describes the case of a 19-year-old man in Germany who presented at the Cologne Early Recognition and Intervention Center with “a marked cognitive decline within [six] months, anhedonia, ambivalence, social withdrawal, poverty of speech, and brief, limited intermittent psychotic symptoms, particularly delusions and hallucinations.”

CBD 294
article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The full presentation is available at: [link].

Data 100